Development of a novel mouse glioma model using lentiviral vectors

Tomotoshi Marumoto1, Ayumu Tashiro, Dinorah Friedmann-Morvinski

  • 1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Nature Medicine
|January 6, 2009
PubMed

Insights

Researchers developed a novel method to create glioblastoma multiforme models in mice using lentiviral vectors. This technique allows for precise, cell-type-specific induction of brain tumors in adult animals.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with limited treatment options.
  • Accurate preclinical models are crucial for understanding GBM pathogenesis and developing new therapies.

Purpose of the Study:

  • To develop a novel, region- and cell type-specific method for inducing glioblastoma multiforme in adult immunocompetent mice.
  • To utilize Cre-loxP-controlled lentiviral vectors for targeted oncogene expression.

Main Methods:

  • Injection of Cre-loxP-controlled lentiviral vectors expressing Harvey-Ras and AKT oncogenes into specific brain regions (hippocampus, subventricular zone, cortex) of mice heterozygous for Tp53.
  • Analysis of tumor formation, characterization of tumor cells (CD133 expression, tumorsphere formation, differentiation potential).

Main Results:

  • Glioblastoma multiforme was successfully induced in the subventricular zone and hippocampus, but rarely in the cortex.
  • Transplanted tumor cells formed glioblastoma multiforme-like tumors with stem cell markers (CD133+) and differentiation capacity.
  • The method allows for cell type- and region-specific tumor induction.

Conclusions:

  • Cre-loxP-controlled lentiviral vectors provide a novel and effective tool for generating region- and cell type-specific mouse models of glioblastoma multiforme.
  • These models can recapitulate key features of human GBM, including stem cell properties and differentiation.
  • This approach facilitates the study of GBM in a more controlled and relevant preclinical setting.